BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15642213)

  • 1. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
    Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
    Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expressions of Snail, Slug and KAI1 proteins in cervical carcinoma and their clinicopathological significance].
    Gong X; Tao Y; Zhou L; Yu L; Wu S; Song W; Wang D; Cheng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1733-8. PubMed ID: 26714907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer.
    Schindl M; Birner P; Bachtiary B; Breitenecker G; Selzer E; Oberhuber G
    Anticancer Res; 2000; 20(6B):4551-5. PubMed ID: 11205303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of autophagy gene Beclin 1 in cervical squamous cell carcinoma].
    Wang ZH; Peng ZL; Duan ZL; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):860-3. PubMed ID: 17236580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
    Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
    World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of Wnt-11 and squamous cell carcinoma antigen expression in cervical cancer.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang J; Luo Q; Su Y; Zhang S
    Med Oncol; 2014 May; 31(5):933. PubMed ID: 24737009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP3 expression is associated with poor survival in cervical squamous cell carcinoma.
    Wei Q; Yan J; Fu B; Liu J; Zhong L; Yang Q; Zhao T
    Hum Pathol; 2014 Nov; 45(11):2218-24. PubMed ID: 25176620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix].
    Nai MM; Yin RT; Xie C; Kang DY; Tang XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):236-9. PubMed ID: 19462897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
    Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
    Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.
    Zhou JH; Ye F; Chen HZ; Zhou CY; Lu WG; Xie X
    Life Sci; 2006 Apr; 78(22):2643-9. PubMed ID: 16434060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
    Zhou XL; Wang M
    Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
    Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
    Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
    Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
    Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H
    Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.